Stockreport

Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F

Inventiva S.A. - American Depository Shares  (IVA) 
PDF Daix (France), New York City (New York, United States), April 8, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (the “Company”), a clinical-stage biopharmaceutical co [Read more]